IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IOVA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/25	05:01	GlobeNewswire Inc.	Iovance Biotherapeutics to Present at Upcoming Conferences and Events	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/24	06:00	GlobeNewswire Inc.	Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/18	06:15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/18	06:15	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/10	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/10	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/10	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/10	05:01	GlobeNewswire Inc.	Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/05/01	19:01	GlobeNewswire Inc.	Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/04/30	19:01	GlobeNewswire Inc.	Iovance Biotherapeutics to Present at Upcoming Conferences	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/04/25	05:01	GlobeNewswire Inc.	Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/04/20	06:15	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/23	06:30	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/07	08:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/06	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/06	07:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/06	07:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/06	07:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/06	07:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/06	07:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/04	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/04	20:30	GlobeNewswire Inc.	Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/03/02	07:00	GlobeNewswire Inc.	Iovance Biotherapeutics to Present at Upcoming Conferences	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/29	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/29	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/29	06:01	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/23	06:53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/22	22:45	GlobeNewswire Inc.	Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/22	06:44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/02/21	07:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc